0000950170-24-111805.txt : 20241002 0000950170-24-111805.hdr.sgml : 20241002 20241002184820 ACCESSION NUMBER: 0000950170-24-111805 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241002 DATE AS OF CHANGE: 20241002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mazzariello Gina CENTRAL INDEX KEY: 0001913765 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41199 FILM NUMBER: 241349337 MAIL ADDRESS: STREET 1: C/O AMYLYX PHARMACEUTICALS, INC. STREET 2: 43 THORNDIKE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Amylyx Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001658551 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 464600503 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 43 THORNDIKE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-683-0917 MAIL ADDRESS: STREET 1: 43 THORNDIKE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02141 4 1 ownership.xml 4 X0508 4 2024-09-30 0001658551 Amylyx Pharmaceuticals, Inc. AMLX 0001913765 Mazzariello Gina C/O AMYLYX PHARMACEUTICALS, INC. 43 THORNDIKE STREET CAMBRIDGE MA 02141 false true false false Chief Legal Officer false Common Stock 2024-09-30 4 S false 8709 3.1967 D 142768 D Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.12 to $3.235. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. /s/ Joshua B. Cohen, as Attorney in Fact 2024-10-02